Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

The oncology market in Canada

Ten per cent is not enough - simple estimates of the Canadian oncology market overlook a complex picture

EU flag

MEPs agree clinical trial regulation revision

Paves way for EU trial database and simplified online applications for new studies

- PMLiVE

Janssen’s Sirturo wins backing for conditional EU licence

CHMP recommends first-in-class multidrug-resistant tuberculosis treatment

- PMLiVE

Cegedim’s physician network Docnet set for US debut

Online healthcare professional community will have phased launch from 2014

Actelion HQ Switzerland

Actelion gets EU nod for Tracleer follow-up

European decision on Opsumit follows its recent US approval

- PMLiVE

Skills in healthcare: pharmacy challenges in the UK

The challenges today’s pharmacists face

- PMLiVE

Jazz offers $1bn for Italy’s Gentium

Will gain access to recently-approved liver drug Defitelio

- PMLiVE

ABPI reprimands for four pharma firms

Allergan, Shire Pharmaceuticals, Gedeon Richter and Sanofi breach Code of Practice

- PMLiVE

BIA: Political compromises could undermine EU trial reform

UK biotech body speaks out on eve of crucial committee hearing

- PMLiVE

The cost of doing business

External pressures, like ‘defensive medicine’, need to be counted when it comes to healthcare costs

Warehousing of HCV patients reaches new high

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

Inizio

Brand leaders in RA will lose market share, predict rheumatologists

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links